Tomas Lindahl

Last updated

Tomas Lindahl

FRS FMedSci
Tomas Lindahl 0113.jpg
Tomas Lindahl at the Royal Swedish Academy of Sciences (2015)
Born
Tomas Robert Lindahl

(1938-01-28) 28 January 1938 (age 85) [1]
Stockholm, Sweden
Nationality Swedish, naturalised British
(dual nationality)
Alma mater
Known forClarification of cellular resistance to carcinogens
Awards
Scientific career
Fields
Institutions
Thesis On the structure and stability of nucleic acids in solution  (1967)
Website crick.ac.uk/research/a-z-researchers/emeritus-scientists/tomas-lindahl/

Tomas Robert Lindahl FRS [3] FMedSci [5] (born 28 January 1938) is a Swedish-British scientist specialising in cancer research. [7] In 2015, he was awarded the Nobel Prize in Chemistry [8] jointly with American chemist Paul L. Modrich and Turkish chemist Aziz Sancar for mechanistic studies of DNA repair. [9] [10] [11]

Contents

Education

Lindahl was born in Kungsholmen, Stockholm, Sweden to Folke Robert Lindahl and Ethel Hulda Hultberg. [12] He received a PhD degree in 1967, [13] and an MD degree qualification in 1970, from the Karolinska Institutet in Stockholm. [1]

Career and research

After obtaining his research doctorate, Lindahl did postdoctoral research at Princeton University and Rockefeller University. [14] He was professor of medical chemistry at the University of Gothenburg 1978–82. After moving to the United Kingdom he joined the Imperial Cancer Research Fund (now Cancer Research UK) as a researcher in 1981. [14] From 1986 to 2005 he was the first Director of Cancer Research UK's Clare Hall Laboratories in Hertfordshire, since 2015 part of the Francis Crick Institute. [15] He continued to research there until 2009. He has contributed to many papers on DNA repair and the genetics of cancer. [16] [17] [18] [19] [20] [21] [22] [23] [24]

Awards and honours

Lindahl was elected an EMBO Member in 1974 [2] and Fellow of the Royal Society (FRS) in 1988, [4] his certificate of election reads:

Dr. Tomas Lindahl is noted for his contributions to the comprehension of DNA repair at the molecular level in bacterial and mammalian cells. He was the first to isolate a mammalian DNA ligase and to describe a totally unanticipated novel group of DNA glycosylases as mediators of DNA excision repair. He has also discovered a unique class of enzymes in mammalian cells, namely the methyltransferases, which mediate the adaptive response to alkylation of DNA and has shown that the expression of these enzymes is regulated by the ada gene. More recently he has elucidated the molecular defect in Blooms syndrome [ sic ] to be the lack of DNA ligase I. Apart from providing profound insights into the nature of the DNA repair process his very important contributions promise to facilitate the design of more selective chemotherapeutic drugs for the treatment of cancer. Lindahl has also made a number of significant contributions to understanding at the DNA level the mechanism of transformation of B-lymphocytes by the Epstein-Barr virus. The most notable of these was the first description of the occurrence in lymphoid cells of closed circular duplex viral DNA. [3]

Lindahl received the Royal Society's Royal Medal in 2007 "making fundamental contributions to our understanding of DNA repair. His achievements stand out for their great originality, breadth and lasting influence." [25] He is a member of the Norwegian Academy of Science and Letters. [26] He was awarded the Copley Medal in 2010. He was elected a founding Fellow of the Academy of Medical Sciences (FMedSci) in 1998. In 2018, he was elected a foreign associate of the National Academy of Sciences.

He shared the Nobel Prize in Chemistry in 2015. [9] The Swedish Academy noted that "The Nobel Prize in Chemistry 2015 was awarded jointly to Tomas Lindahl, Paul Modrich and Aziz Sancar 'for mechanistic studies of DNA repair'." [27]

Related Research Articles

<span class="mw-page-title-main">Cancer Research UK</span> Cancer research and awareness charity

Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.

<span class="mw-page-title-main">DNA repair</span> Cellular mechanism

DNA repair is a collection of processes by which a cell identifies and corrects damage to the DNA molecules that encodes its genome. In human cells, both normal metabolic activities and environmental factors such as radiation can cause DNA damage, resulting in tens of thousands of individual molecular lesions per cell per day. Many of these lesions cause structural damage to the DNA molecule and can alter or eliminate the cell's ability to transcribe the gene that the affected DNA encodes. Other lesions induce potentially harmful mutations in the cell's genome, which affect the survival of its daughter cells after it undergoes mitosis. As a consequence, the DNA repair process is constantly active as it responds to damage in the DNA structure. When normal repair processes fail, and when cellular apoptosis does not occur, irreparable DNA damage may occur, including double-strand breaks and DNA crosslinkages. This can eventually lead to malignant tumors, or cancer as per the two-hit hypothesis.

<span class="mw-page-title-main">John Gurdon</span> English developmental biologist (born 1933)

Sir John Bertrand Gurdon is a British developmental biologist, best known for his pioneering research in nuclear transplantation and cloning.

<span class="mw-page-title-main">Tim Hunt</span> British biochemist; Nobel laureate

Sir Richard Timothy Hunt, is a British biochemist and molecular physiologist. He was awarded the 2001 Nobel Prize in Physiology or Medicine with Paul Nurse and Leland H. Hartwell for their discoveries of protein molecules that control the division of cells. While studying fertilized sea urchin eggs in the early 1980s, Hunt discovered cyclin, a protein that cyclically aggregates and is depleted during cell division cycles.

<span class="mw-page-title-main">Martin Evans</span> British biologist

Sir Martin John EvansFLSW is an English biologist who, with Matthew Kaufman, was the first to culture mice embryonic stem cells and cultivate them in a laboratory in 1981. He is also known, along with Mario Capecchi and Oliver Smithies, for his work in the development of the knockout mouse and the related technology of gene targeting, a method of using embryonic stem cells to create specific gene modifications in mice. In 2007, the three shared the Nobel Prize in Physiology or Medicine in recognition of their discovery and contribution to the efforts to develop new treatments for illnesses in humans.

<span class="mw-page-title-main">Gregory Winter</span> English biochemist (born 1951)

Sir Gregory Paul Winter is a Nobel Prize-winning English molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research career has been based almost entirely at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering, in Cambridge, England.

<span class="mw-page-title-main">Salvador Moncada</span> Honduran pharmacologist and professor

Sir Salvador Enrique Moncada Seidner, FRS, FRCP, FMedSci is a Honduran pharmacologist and professor. He is currently Research Domain Director for Cancer at the University of Manchester.

Michael Samuel Neuberger FRS FMedSci was a British biochemist and immunologist.

<span class="mw-page-title-main">Aziz Sancar</span> Turkish biochemist and molecular biologist

Aziz Sancar is a Turkish-American molecular biologist specializing in DNA repair, cell cycle checkpoints, and circadian clock. In 2015, he was awarded the Nobel Prize in Chemistry along with Tomas Lindahl and Paul L. Modrich for their mechanistic studies of DNA repair. He has made contributions on photolyase and nucleotide excision repair in bacteria that have changed his field.

<span class="mw-page-title-main">London Research Institute</span> Biological research facility

The Cancer Research UK London Research Institute (LRI) was a biological research facility which conducted research into the basic biology of cancer.

Richard D. Wood is an American molecular biologist specializing in research on DNA repair and mutation. He is known for pioneering studies on nucleotide excision repair (NER), particularly for reconstituting the minimum set of proteins involved in this process, identifying proliferating cell nuclear antigen (PCNA) as part of the NER complex and identifying mammalian repair polymerases.

Transcription factor II H (TFIIH) is an important protein complex, having roles in transcription of various protein-coding genes and DNA nucleotide excision repair (NER) pathways. TFIIH first came to light in 1989 when general transcription factor-δ or basic transcription factor 2 was characterized as an indispensable transcription factor in vitro. This factor was also isolated from yeast and finally named TFIIH in 1992.

<span class="mw-page-title-main">Paul L. Modrich</span> American biochemist and Nobel Laureate (born 1946)

Paul Lawrence Modrich is an American biochemist, James B. Duke Professor of Biochemistry at Duke University and Investigator at the Howard Hughes Medical Institute. He is known for his research on DNA mismatch repair. Modrich received the Nobel Prize in Chemistry 2015, jointly with Aziz Sancar and Tomas Lindahl.

<span class="mw-page-title-main">LIG1</span> Protein-coding gene in the species Homo sapiens

DNA ligase 1 is an enzyme that in humans is encoded by the LIG1 gene. DNA ligase I is the only known eukaryotic DNA ligase involved in both DNA replication and repair, making it the most studied of the ligases.

<span class="mw-page-title-main">Adrian Bird</span> British geneticist and professor

Sir Adrian Peter Bird, is a British geneticist and Buchanan Professor of Genetics at the University of Edinburgh. Bird has spent much of his academic career in Edinburgh, from receiving his PhD in 1970 to working at the MRC Mammalian Genome Unit and later serving as director of the Wellcome Trust Centre for Cell Biology. His research focuses on understanding DNA methylation and CpG islands, and their role in diseases such as Rett syndrome.

<span class="mw-page-title-main">Laurence Pearl</span>

Laurence Harris Pearl FRS FMedSci is a British biochemist and structural biologist who is currently Professor of Structural Biology in the Genome Damage and Stability Centre and was Head of the School of Life Sciences at the University of Sussex.

<span class="mw-page-title-main">Shankar Balasubramanian</span> Indian-born British chemist

Sir Shankar Balasubramanian is an Indian-born British chemist and Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge, Senior Group Leader at the Cancer Research UK Cambridge Institute and Fellow of Trinity College, Cambridge. He is recognised for his contributions in the field of nucleic acids. He is scientific founder of Solexa and Cambridge Epigenetix.

<span class="mw-page-title-main">Patrik Rorsman</span>

Patrik Rorsman FRS FMedSci is Professor of Diabetic Medicine at the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), in the Radcliffe Department of Medicine at the University of Oxford and a fellow of Harris Manchester College, Oxford.

<span class="mw-page-title-main">Ketan J. Patel</span>

Ketan Jayakrishna Patel is a British-Kenyan scientist who is Director of the MRC Weatherall Institute of Molecular Medicine and the MRC Molecular Haematology Unit at the University of Oxford. Until 2020 he was a tenured principal investigator at the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB).

Sir David Klenerman is a British biophysical chemist and a professor of biophysical chemistry at the Department of Chemistry at the University of Cambridge and a Fellow of Christ's College, Cambridge.

References

  1. 1 2 "LINDAHL, Tomas Robert" . Who's Who . Vol. 2015 (online Oxford University Press  ed.). A & C Black.(Subscription or UK public library membership required.)
  2. 1 2 "Tomas Lindahl EMBO profile". people.embo.org. Heidelberg: European Molecular Biology Organization.
  3. 1 2 3 "Lindahl, Tomas Robert: EC/1988/20". London: The Royal Society. Archived from the original on 10 July 2019.
  4. 1 2 Anon (1988). "Dr Tomas Lindahl FMedSci FRS". royalsociety.org. London: Royal Society. Archived from the original on 22 September 2015. One or more of the preceding sentences incorporates text from the royalsociety.org website where:
    “All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License.” --Royal Society Terms, conditions and policies at the Wayback Machine (archived September 25, 2015)
  5. 1 2 "Dr Tomas Lindahl FRS FMedSci". London: Academy of Medical Sciences. Archived from the original on 8 October 2015.
  6. ↑ Lindahl, Tomas (2013). "My Journey to DNA Repair". Genomics, Proteomics & Bioinformatics. 11 (1): 2–7. doi:10.1016/j.gpb.2012.12.001. ISSN   1672-0229. PMC   4357663 . PMID   23453014.
  7. ↑ "Emeritus Scientist – Tomas Lindahl". The Crick. Archived from the original on 1 December 2015.
  8. ↑ Tomas Lindahl – Nobel Prize in Chemistry 2015 on Vimeo
  9. 1 2 Broad, William J. (7 October 2015). "Nobel Prize in Chemistry Awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar for DNA Studies". The New York Times. ISSN   0362-4331 . Retrieved 7 October 2015.
  10. ↑ Staff (7 October 2015). "THE NOBEL PRIZE IN CHEMISTRY 2015 – DNA repair – providing chemical stability for life" (PDF). Nobel Prize . Retrieved 7 October 2015.
  11. ↑ Cressey, Daniel (2015). "DNA repair sleuths win chemistry Nobel: Tomas Lindahl, Paul Modrich and Aziz Sancar share 2015 prize". Nature. 526 (7573): 307–8. doi: 10.1038/nature.2015.18515 . ISSN   1476-4687. PMID   26469021.
  12. ↑ Sweden, Indexed Birth Records, 1860–1941
  13. ↑ Lindahl, Tomas (1967). On the structure and stability of nucleic acids in solution. Stockholm.{{cite book}}: CS1 maint: location missing publisher (link)
  14. 1 2 "Cancer Research UK Grants & Research – Tomas Lindahl" . Retrieved 10 November 2008.
  15. ↑ "4 ways that Tomas Lindahl’s Nobel Prize for Chemistry revolutionised cancer research", by Emma Smith, CRUK Science blog, 7 October 2015
  16. ↑ Gerken, T. is; Girard, C. A.; Tung, Y. -C. L.; Webby, C. J.; Saudek, V.; Hewitson, K. S.; Yeo, G. S. H.; McDonough, M. A.; Cunliffe, S.; McNeill, L. A.; Galvanovskis, J.; Rorsman, P.; Robins, P.; Prieur, X.; Coll, A. P.; Ma, M.; Jovanovic, Z.; Farooqi, I. S.; Sedgwick, B.; Barroso, I.; Lindahl, T.; Ponting, C. P.; Ashcroft, F. M.; O'Rahilly, S.; Schofield, C. J. (2008). "The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase". Science. 318 (5855): 1469–1472. Bibcode:2007Sci...318.1469G. doi:10.1126/science.1151710. PMC   2668859 . PMID   17991826.
  17. ↑ Tomas Lindahl's publications indexed by the Scopus bibliographic database. (subscription required)
  18. ↑ Lindahl, T. (1993). "Instability and decay of the primary structure of DNA". Nature. 362 (6422): 709–15. Bibcode:1993Natur.362..709L. doi:10.1038/362709a0. PMID   8469282. S2CID   4283694.
  19. ↑ Wood, R. D. (2001). "Human DNA Repair Genes". Science. 291 (5507): 1284–9. Bibcode:2001Sci...291.1284W. doi:10.1126/science.1056154. PMID   11181991.
  20. ↑ Satoh, M. S.; Lindahl, T. (1992). "Role of poly(ADP-ribose) formation in DNA repair". Nature. 356 (6367): 356–8. Bibcode:1992Natur.356..356S. doi:10.1038/356356a0. PMID   1549180. S2CID   4364270.
  21. ↑ Trewick, S. C.; Henshaw, T. F.; Hausinger, R. P.; Lindahl, T; Sedgwick, B (2002). "Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage". Nature. 419 (6903): 174–8. Bibcode:2002Natur.419..174T. doi:10.1038/nature00908. PMID   12226667. S2CID   4324333.
  22. ↑ Barnes, D. E.; Lindahl, T (2004). "Repair and genetic consequences of endogenous DNA base damage in mammalian cells". Annual Review of Genetics. 38: 445–76. doi:10.1146/annurev.genet.38.072902.092448. PMID   15568983.
  23. ↑ Yang, Y. G.; Lindahl, T; Barnes, D. E. (2007). "Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease". Cell. 131 (5): 873–86. doi: 10.1016/j.cell.2007.10.017 . PMID   18045533. S2CID   2332259.
  24. ↑ Crow, Y. J.; Hayward, B. E.; Parmar, R; Robins, P; Leitch, A; Ali, M; Black, D. N.; Van Bokhoven, H; Brunner, H. G.; Hamel, B. C.; Corry, P. C.; Cowan, F. M.; Frints, S. G.; Klepper, J; Livingston, J. H.; Lynch, S. A.; Massey, R. F.; Meritet, J. F.; Michaud, J. L.; Ponsot, G; Voit, T; Lebon, P; Bonthron, D. T.; Jackson, A. P.; Barnes, D. E.; Lindahl, T (2006). "Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus". Nature Genetics. 38 (8): 917–20. doi:10.1038/ng1845. PMID   16845398. S2CID   9069106.
  25. ↑ "Royal recent winners" . Retrieved 10 November 2008.
  26. ↑ "Gruppe 6: Cellebiologi og molekylærbiologi" (in Norwegian). Norwegian Academy of Science and Letters . Retrieved 7 October 2010.
  27. ↑ "The Nobel Prize in Chemistry 2015". nobelprize.org.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.